- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT05489263
A Predictive Score System for AKI Following Pediatric Cardiac Surgery
Derivation and Validation of A Predictive Score System for Acute Kidney Injury Following Pediatric Cardiac Surgery
Aperçu de l'étude
Statut
Intervention / Traitement
Description détaillée
The development of AKI is common following cardiac surgery whether in adult or pediatric population. Not only severe AKI like dialysis support, but also mild kidney injury has profound influence on increased subsequent morbidities and mortality.
Pediatric patients who undergo cardiac procedures are characterized by lower weight, younger age, complicated cardiac anomaly and poor resistance to surgical insults. Thus, in comparison with adults, their AKI risk is relatively higher.
At present there has been no specific intervention regarding AKI prevention and therapy. Establishing a risk score based on patient characteristics and surgical information to effectively predict postoperative AKI risk is therefore imperative. It can serve as a decision-making tool to facilitate patient management with regard to kidney prognosis.
This program is aimed at developing and internally validating a AKI risk score post cardiac surgery in a Chinese pediatric population.
Type d'étude
Inscription (Anticipé)
Contacts et emplacements
Coordonnées de l'étude
- Nom: Jianhui Wang, MD
- Numéro de téléphone: +86-010-88398082;
- E-mail: stewenwang@sina.com
Lieux d'étude
-
-
Beijing
-
Beijing, Beijing, Chine, 100037
- Recrutement
- Fuwai Hospital
-
Contact:
- Jianhui Wang, M.D.
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- < 18 years old
- Pediatric patients undergoing cardiac surgery in Fuwai Hospital
Exclusion Criteria:
- Supported by dialysis for renal failure prior to cardiac procedure
- Previously received a renal transplant
- Lack of preoperative or postoperative serum creatinine measurements
- Guardians' refusal on informed consent sign
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Modèles d'observation: Cas-témoins
- Perspectives temporelles: Éventuel
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
---|---|
AKI
AKI is defined by KDIGO criterion based on peri-operative serum creatinine variation.
|
Aucune intervention
|
No-AKI
No-AKI is defined by KDIGO criterion based on peri-operative serum creatinine variation.
|
Aucune intervention
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
The Prevalence of Acute Kidney Injury
Délai: Up to postoperative 7 days
|
Acute Kidney Injury was defined by Kidney Disease Improving Global Outcomes (KDIGO) Criteria.
Accordingly, AKI was classified as stage 1, stage 2 and stage 3.
|
Up to postoperative 7 days
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
The incidence of dialysis
Délai: Up to postoperative 7 days
|
The therapeutic approach to correct renal failure
|
Up to postoperative 7 days
|
The hours of mechanical ventilation
Délai: Up to postoperative 7 days
|
Time before first extubation
|
Up to postoperative 7 days
|
The incidence of reinbutation
Délai: Up to hospital discharge, an average of 7 days
|
Need for postoperative endotracheal intubation given the occurrence of respiratory or non-respiratory complication after extubation.
|
Up to hospital discharge, an average of 7 days
|
The incidence of tracheotomy
Délai: Up to hospital discharge, an average of 7 days
|
The necessary treatment for postoperative respiratory failure
|
Up to hospital discharge, an average of 7 days
|
The incidence of re-operation
Délai: Up to hospital discharge, an average of 7 days
|
Re-exploration prescribed by surgeons due to cardiac issues or excessive chest drainage volume.
|
Up to hospital discharge, an average of 7 days
|
The incidence of mechanical cardiac support
Délai: Up to hospital discharge, an average of 7 days
|
Supported by extracorporeal membrane oxygenation from operative day to discharge or death
|
Up to hospital discharge, an average of 7 days
|
The incidence of mortality
Délai: Up to hospital discharge, an average of 7 days
|
Specific death reason
|
Up to hospital discharge, an average of 7 days
|
The incidence of pulmonary infection
Délai: Up to hospital discharge, an average of 7 days
|
Assessed by relevant guidelines of pulmonary infection
|
Up to hospital discharge, an average of 7 days
|
The cost of medical resources
Délai: Up to hospital discharge, an average of 7 days
|
The RMB patients spend during the whole hospitalization
|
Up to hospital discharge, an average of 7 days
|
Intensive Care Unit Discharge Time
Délai: Up to ICU discharge, an average of 5 days
|
Time and date when the patient is transferred to ward
|
Up to ICU discharge, an average of 5 days
|
Hospital Discharge Time
Délai: Up to hospital discharge, an average of 7 days
|
Time and date when the patient is discharged from the hospital
|
Up to hospital discharge, an average of 7 days
|
The relative change of left ventricular ejection fraction (LVEF) from baseline to hospital discharge
Délai: Up to hospital discharge, an average of 7 days
|
(LVEF at hospital discharge - LVEF at baseline)/LVEF at baseline * 100%
|
Up to hospital discharge, an average of 7 days
|
The relative change of left ventricular end-diastolic diameter (LVEDD) from baseline to hospital discharge
Délai: Up to hospital discharge, an average of 7 days
|
(LVEDD at hospital discharge - LVEDD at baseline)/LVEDD at baseline * 100%
|
Up to hospital discharge, an average of 7 days
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
The relative change of left ventricular ejection fraction (LVEF) from baseline to postoperative 1 year
Délai: Up to postoperative 1 year
|
(LVEF at 1 year - LVEF at baseline)/LVEF at baseline * 100%
|
Up to postoperative 1 year
|
The relative change of left ventricular end-diastolic diameter (LVEDD) from baseline to postoperative 1 year
Délai: Up to postoperative 1 year
|
(LVEDD at 1 year - LVEDD at baseline)/LVEDD at baseline * 100%
|
Up to postoperative 1 year
|
Collaborateurs et enquêteurs
Les enquêteurs
- Chercheur principal: Jianhui Wang, MD, Department of Anesthesiology, Fuwai Hospital, Chinese Academy of Medial Sciences
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Anticipé)
Achèvement de l'étude (Anticipé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 2021-LC15
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Lésion rénale aiguë
-
Kessler FoundationInstituto Vocacional Enrique Díaz de León A.C., Guadalajara, MexicoRecrutementTBI (Traumatic Brain Injury) ou MS (Sclérose en Plaques)États-Unis, Espagne
Essais cliniques sur Aucune intervention
-
Otsuka Pharmaceutical Factory, Inc.CelerionComplété
-
University of MinnesotaComplété
-
Assistance Publique - Hôpitaux de ParisComplété
-
Milton S. Hershey Medical CenterPas encore de recrutementMaladies du foie | NASH - Stéatohépatite non alcoolique | NASH
-
University of CologneComplétéAccident vasculaire cérébral | ApraxieAllemagne
-
Northwestern UniversityComplétéLa dépression | AnxiétéÉtats-Unis
-
Eunah Cho, MDComplétéRécupération postopératoireCorée, République de
-
H2O Health and Agriculture LLCInconnuePneumonie | DiarrhéeGuatemala
-
University of California, Los AngelesInconnue
-
Johns Hopkins UniversityAstraZenecaInscription sur invitationCancer du poumon non à petites cellules (NSCLC)États-Unis